Sep 2026
SMARCA4-deficient Anaplastic Thyroid Carcinoma: A Hitherto Unreported Case.
Khushi Naik, Neha Mittal, Nupur Karnik et al.
· Virchows Archiv · 0 citations
We have 2 of 119 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
KRAS-mutant NSCLC is transitioning from historically untargetable disease to a therapeutically actionable subset, and future progress hinges on resistance-directed combinations, biomarker-guided personalization, expansion to non-G12C mutants, and evaluation in earlier disease settings.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.